Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 28-01-2016 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Establishment of Research Joint Venture | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Simmons and Simmons advised GlaxoSmithKline on the establishment of an innovative joint venture investment fund.
The joint venture fund was established through a limited liability partnership entity under the name Apollo Therapeutics LLP between GlaxoSmithKline, Johnson and Johnson Innovation and AstraZeneca, Imperial Innovations, UCL Business and Cambridge Enterprise. The core objective of the joint venture was to fill a funding gap that would see academically funded biomedical research transform into mature and qualitative drug discovery projects.
|
||
| Financial Center: | London | Value: | 0.00-0.00 |
| Advised Party: | Joint Venture Party | Law Firm | Simmons & Simmons |
| JV Party Jurisdiction | United Kingdom | JV Party Jurisdiction | United Kingdom |
| Classification: |
Joint Ventures Continuing Business Partnership |
Lawyer | Michael Gavey |
